Literature DB >> 18059335

A novel function for HSF1-induced mitotic exit failure and genomic instability through direct interaction between HSF1 and Cdc20.

Y J Lee1, H J Lee, J S Lee, D Jeoung, C M Kang, S Bae, S J Lee, S H Kwon, D Kang, Y S Lee.   

Abstract

Although heat-shock factor (HSF) 1 is a known transcriptional factor of heat-shock proteins, other pathways like production of aneuploidy and increased protein stability of cyclin B1 have been proposed. In the present study, the regulatory domain of HSF1 (amino-acid sequence 212-380) was found to interact directly with the amino-acid sequence 106-171 of Cdc20. The association between HSF1 and Cdc20 inhibited the interaction between Cdc27 and Cdc20, the phosphorylation of Cdc27 and the ubiquitination activity of anaphase-promoting complex (APC). The overexpression of HSF1 inhibited mitotic exit and the degradations of cyclin B1 and securin, which resulted in production of aneuploidy and multinucleated cells, but regulatory domain-deficient HSF1 did not. Moreover, HSF1-overexpressing cells showed elevated levels of micronuclei and genomic alteration. The depletion of HSF1 from cells highly expressing HSF1 reduced nocodazole-mediated aneuploidy in cells. These findings suggest a novel function of HSF1 frequently overexpressed in cancer cells, to inhibit APC/C activity by interacting with Cdc20, and to result in aneuploidy development and genomic instability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059335     DOI: 10.1038/sj.onc.1210966

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

Authors:  Aldo M Roccaro; Antonio Sacco; Brian Thompson; Xavier Leleu; Abdel Kareem Azab; Feda Azab; Judith Runnels; Xiaoying Jia; Hai T Ngo; Molly R Melhem; Charles P Lin; Domenico Ribatti; Barrett J Rollins; Thomas E Witzig; Kenneth C Anderson; Irene M Ghobrial
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

2.  Polymorphisms in human heat shock factor-1 and analysis of potential biological consequences.

Authors:  Tiffany M Bridges; Rachel G Scheraga; Mohan E Tulapurkar; Dante Suffredini; Stephen B Liggett; Aparna Ramarathnam; Ratnakar Potla; Ishwar S Singh; Jeffrey D Hasday
Journal:  Cell Stress Chaperones       Date:  2014-07-16       Impact factor: 3.667

3.  PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27.

Authors:  Laura A Link; Breege V Howley; George S Hussey; Philip H Howe
Journal:  Mol Cancer Res       Date:  2016-04-21       Impact factor: 5.852

Review 4.  Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

Authors:  Agnieszka Toma-Jonik; Natalia Vydra; Patryk Janus; Wiesława Widłak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-10       Impact factor: 6.730

5.  Anaphase-promoting complex/cyclosome participates in the acute response to protein-damaging stress.

Authors:  Johanna K Ahlskog; Johanna K Björk; Alexandra N Elsing; Camilla Aspelin; Marko Kallio; Pia Roos-Mattjus; Lea Sistonen
Journal:  Mol Cell Biol       Date:  2010-10-11       Impact factor: 4.272

6.  microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Changzhong Chen; Judith Runnels; Xavier Leleu; Feda Azab; Abdel Kareem Azab; Xiaoying Jia; Hai T Ngo; Molly R Melhem; Nicholas Burwick; Lyuba Varticovski; Carl D Novina; Barrett J Rollins; Kenneth C Anderson; Irene M Ghobrial
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

7.  Heat shock transcription factor 1 is activated as a consequence of lymphocyte activation and regulates a major proteostasis network in T cells critical for cell division during stress.

Authors:  Siva K Gandhapudi; Patience Murapa; Zachary D Threlkeld; Martin Ward; Kevin D Sarge; Charles Snow; Jerold G Woodward
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 8.  HSF1 as a Cancer Biomarker and Therapeutic Target.

Authors:  Richard L Carpenter; Yesim Gökmen-Polar
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

9.  HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.

Authors:  Marc L Mendillo; Sandro Santagata; Martina Koeva; George W Bell; Rong Hu; Rulla M Tamimi; Ernest Fraenkel; Tan A Ince; Luke Whitesell; Susan Lindquist
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

Review 10.  Heat Shock Factor 1 as a Prognostic and Diagnostic Biomarker of Gastric Cancer.

Authors:  Woong Kim; Seok-Jun Kim
Journal:  Biomedicines       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.